EVA (Evolutionary Air), the newest Powered Air-Purifying Respirator (PAPR) from Bullard, is now approved by the National Institute for Occupational Safety and Health (NIOSH) with a combination chemical and particulate filter that protects users against organic vapors, chloride dioxide, chlorine, hydrogen chloride, hydrogen fluoride, sulfur dioxide and particulates at a high efficiency level.
EVA (Evolutionary Air), the newest Powered Air-Purifying Respirator (PAPR) from Bullard, is now approved by the National Institute for Occupational Safety and Health (NIOSH) with a combination chemical and particulate filter that protects users against organic vapors, chloride dioxide, chlorine, hydrogen chloride, hydrogen fluoride, sulfur dioxide and particulates at a high efficiency level.
Bullard designed EVA from input received from users and experts in the field and the result is a technologically-advanced PAPR that offers constant air flow in a compact, ergonomic, lightweight design. Offering 1,000 Assigned Protection Factor, EVA is equipped with an innovative Active Flow Technology system that automatically maintains constant air flow and an easy-to-read fuel gauge that lets the user quickly check the units battery status.
Additional EVA features include:
-- Two distinct audible alarms that notify wearers of low battery and low air flow. The sound from the alarms travels through the breathing tube directly to the users ear.
-- A long-lasting 10,000-hour brushless motor that is designed for long-term reliable use.
-- Two-speed blower so the user can choose more or less cooling and air flow.
-- Filter locking tab that notifies the user that the filter is in place with both a visual indication and audible click.
-- Contoured belt made of closed-cell, chemically-resistant foam shaped to contour to the wearers back for extra comfort.
EVA is NIOSH approved with Bullard Tychem® Hoods and Loose-Fitting Hoods, Spectrum® Series Full Facepiece, and the FAMB Series Half-Mask.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.